Clover Health Investments, Corp.
CLOV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,371,131 | $1,260,543 | $1,096,552 | $1,471,996 |
| % Growth | 8.8% | 15% | -25.5% | – |
| Cost of Goods Sold | $1,006,327 | $1,004,590 | $993,073 | $1,551,178 |
| Gross Profit | $364,804 | $255,953 | $103,479 | -$79,182 |
| % Margin | 26.6% | 20.3% | 9.4% | -5.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $408,934 | $440,246 | $482,403 | $445,745 |
| SG&A Expenses | $408,934 | $440,246 | $482,403 | $445,745 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,619 | $21,036 | -$92,260 | $112,065 |
| Operating Expenses | $410,553 | $461,282 | $390,143 | $557,810 |
| Operating Income | -$45,749 | -$205,329 | -$286,664 | -$636,992 |
| % Margin | -3.3% | -16.3% | -26.1% | -43.3% |
| Other Income/Exp. Net | -$517 | -$4,819 | $32,080 | $49,236 |
| Pre-Tax Income | -$46,266 | -$210,148 | -$254,584 | -$587,756 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$43,009 | -$213,361 | -$339,567 | -$587,756 |
| % Margin | -3.1% | -16.9% | -31% | -39.9% |
| EPS | -0.088 | -0.45 | -0.71 | -1.25 |
| % Growth | 80.5% | 36.6% | 43.2% | – |
| EPS Diluted | -0.088 | -0.45 | -0.71 | -1.25 |
| Weighted Avg Shares Out | 490,019 | 482,176 | 476,244 | 470,852 |
| Weighted Avg Shares Out Dil | 490,019 | 482,176 | 476,244 | 470,852 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $7 | $1,363 | $16,910 |
| Depreciation & Amortization | $1,331 | $2,509 | $1,187 | $1,246 |
| EBITDA | -$44,935 | -$207,632 | -$252,034 | -$569,600 |
| % Margin | -3.3% | -16.5% | -23% | -38.7% |